CAS: 203191-10-0; 2-((2-(3,4-Dimethoxyphenyl)-5-Methoxy-4-Oxo-4H-Chromen-7-yl)Oxy)Acetic Acid

该化合物是合成有机化合物,其结构复杂,包括苯丙胺和多种甲氧组,其特征为合成有机化合物,该化合物通常具有与苯丙胺化合物相关的特性,例如潜在的抗氧化活动,因为存在芳香环和甲基氧代成分,该化合物独特的结构和功能组群有助于其在药物开发中的潜在应用,并成为生物化学和药理学的研究工具.

结构式图片

上下游产品

7-hydroxy-6,3',4'-trimethoxyflavone 7-ethyloxycarbonylmethyloxy-3',4',5-trimethoxy flavone 7-t-butyloxycarbonylmethyloxy-3',4',5-trimethoxy flavone 3',5,7-trihydroxy-4'-methoxy flavone-7-rutinoside7-carboxymethyloxy-3',4',5-trimethoxy flavone monohydrate 7-{(carbamylcarbamoyl)methyloxy}-3',4',5-trimethoxyflavone 7-{(formylcarbamoyl)methyloxy}-3',4',5-trimethoxyflavone 7-{(N-cyan°Carbamoyl)-methyloxy}-3',4',5-trimethoxyflavone

合成工艺路线路线简述

  • 合成目标产物 Da-6034 主要起始原料 Acetic Acid, 2-[[2-(3,4-Dimethoxyphenyl)-5-Methoxy-4-Oxo-4H-1-Benzopyran-7-Yl]Oxy]-, Ethyl Ester
  • (文献来源)合成步骤主要原料 Acetic Acid, 2-[[2-(3,4-Dimethoxyphenyl)-5-Methoxy-4-Oxo-4H-1-Benzopyran-7-Yl]Oxy]-, Ethyl Ester

海关参考信息

专利信息


专利号:US-7371775-B2
优先权日:2003-09-04
标题:7-carboxymethyloxy-3′,4′,5-trimethoxy flavone monohydrate, the preparation method and uses thereof
发明人:YOO MOOHI; KIM DONG SUNG; KIM YONG DUCK; KIM WONBAE
权利人:DONG A PHARMACEUTICALS CO LTD
摘要:The present invention relates to 7-carboxymethyloxy-3′,4′,5-trimethoxy flavone.monohydrate which is a non hygroscopic product suitable for the preparation of metered dose of 7-carboxymethyloxy-3′,4′,5-trimethoxy flavone having protective activity for gastrointestinal tract including the colon, and a preparation method and uses thereof. 7-carboxymethyloxy-3′,4′,5-trimethoxy flavone.monohydrate of the present invention has advantages such as mucus protecting activity for gastrointestinal tract including the colon, convenience for handling and storage under ordinary humidity owing to its non-hygroscopicity, and ability to contain an active compound consistently for the formulation production of a medicine. In addition, the preparation method of 7-carboxymethyloxy-3′,4′,5-trimethoxy flavone.monohydrate of the present invention reduces long steps of total synthesis and requires mild conditions for the production of a compound because autoclave condition is not necessary for methylation in this case, and makes mass-production possible without any purification process such as recrystallization or column chromatography.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Lee H, Kim EK, Kim JY, Yang YM, Shin DM, Kang KK, Kim TI. DA-6034-induced mucin secretion via Ca2+-dependent pathways through P2Y receptor stimulation. Invest Ophthalmol Vis Sci. 2014 Sep 11;55(10):6565-74. doi: 10.1167/iovs.14-13875. doi: 10.4196/kjpp.2014.18.2.89. Epub 2014 Apr 3.
3: Lee J, Shin KH, Kim JR, Lim KS, Jang IJ, Chung JY. Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers. Clin Drug Investig. 2014 Jan;34(1):37-42. doi: 10.1007/s40261-013-0147-0. doi: 10.1111/j.1440-1746.2011.06873.x. doi: 10.1111/j.1365-3083.2011.02577.x. doi: 10.3109/02713680903453494. doi: 10.1089/jop.2008.0126. doi: 10.1016/j.ijpharm.2007.12.042. Epub 2008 Jan 9. doi: 10.3181/0707-RM-186. Epub 2007 Apr 4. Epub 2006 Jan 4.

合成参考文献


参考文献:10.1111/j.1365-3083.2011.02577.x
摘要:Ko SH, Yoo DY, Kim YJ, Choi SM, Kang KK, Kim H, Kim N, Kim JS, Kim JM. A mechanism for the action of the compound DA-6034 on NF-κB pathway activation in Helicobacter pylori-infected gastric epithelial cells. Scand J Immunol. 2011 Sep;74(3):253–63. doi: 10.1111/j.1365-3083.2011.02577.x.
参考文献:10.1007/s13277-012-0621-y
摘要:Park BB, Yoon Js, Kim Es, Choi J, Won Yw, Choi Jh, Lee YY. Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells. Tumour Biol. 2013 Apr;34(2):875–85. doi: 10.1007/s13277-012-0621-y.
摘要:S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知